85706-52-1

Usage

InChI:InChI=1/C10H13Br3O/c1-9(4-11)6-2-3-10(9,5-12)8(14)7(6)13/h6-7H,2-5H2,1H3

Upstream product

• 464-49-3 (1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one 
• 10293-06-8 (1R)-3-endo-bromocamphor 
• 1217497-39-6 (+)-endo-3,9-dibromocamphor 
• 10293-10-4 3-endo-9-dibromo-1,7,7-trimethylbicyclo<2.2.1>heptan-2-one 

Downstream Products

• 85706-53-2 (+)-endo-9,10-dibromocamphor 
• 98049-45-7 (1'R,2'R)-2-(2'-bromomethyl-2'-methyl-3'-methylenecyclopentyl)ethanoic acid 
• 85706-53-2 (1S)-9,10-dibromocamphor 
• 10293-09-1 (1R,4R,7R)-9-bromocamphor 
• 104672-33-5 (-)-anti-7,9-dibromofenchone 

Relevant academic research and scientific papers

An enantiospecific route to C,D ring synthons for steroid synthesis

A simple enantiospecific route to a hydrindenone intermediate for steroid synthesis has been accomplished.The introduction of a wide variety of side-chain units is made possible by stereoselective alkylation of a bicyclic ester 13 derived from (+)-camphor

Ring cleavage of camphor derivatives: formation of chiral synthons for natural products synthesis

Base-promoted ring cleavage of 9,10- and 8,10-dibromocamphor provides chiral intermediates for natural product synthesis.

Synthesis of 8,10-and 9,10-disubstituted camphor derivatives

Regiospecific bromination and debromination reactions have been used to provide a synthetic route from camphor to optically active 8,10- and 9,10-disubstituted camphor derivatives.